Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

Your search for ‘Rothwell, Figg, Ernst & Manbeck, P.C.’ returned 53 results

Use advanced search filters to refine your search

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Geographical Indications In The EU: A Step Forward In The Protection Of Traditional Artisanal Skills

    While the European Union acceded to the Geneva Act at the end of 2019, there is still no implemented protection regime for CIPs.
    European UnionIntellectual Property
    Rothwell, Figg, Ernst & Manbeck, P.C.
    Rothwell, Figg, Ernst & Manbeck, P.C.
  • Article

    Is More Patent Reform Necessary?

    With high profile battles between electronics giants like Apple® and Samsung®, patent related stories have become common place in the American news cycle.
    United StatesIntellectual Property
    Rothwell, Figg, Ernst & Manbeck, P.C.
    Rothwell, Figg, Ernst & Manbeck, P.C.
Article

MRNA IP 2022 Year In Review: Pioneers Clash In Major Patent Litigations

Substantial patent litigation activity occurred in the mRNA space in 2022, involving nearly all of the major mRNA and lipid nanoparticle (LNP) pioneers.
United StatesIntellectual Property
Rothwell, Figg, Ernst & Manbeck, P.C.
Rothwell, Figg, Ernst & Manbeck, P.C.
  • Article

    In Qualcomm v. Apple, Federal Circuit Rules Out Applicant Admitted Prior Art As The "Basis" For Inter Partes Review

    On the first of February, in Qualcomm Inc. v. Apple Inc., the CAFC vacated and remanded the Patent Trial and Appeal Board on two IPR decisions that held claims 1, 2, 5-9, 12, 13, and 16-22 of Qualcomm's U.S. Patent No. 8,063,674 ...
    United StatesIntellectual Property
    Rothwell, Figg, Ernst & Manbeck, P.C.
    Rothwell, Figg, Ernst & Manbeck, P.C.
  • Article

    The Expansion Of IPR Estoppel – Potential Win For Patent Owners

    Since its inception, the PTAB has gained a negative reputation among patent owners, even being referred to as "patent death squads."
    United StatesIntellectual Property
    Rothwell, Figg, Ernst & Manbeck, P.C.
    Rothwell, Figg, Ernst & Manbeck, P.C.
  • Article

    Fashion Meets Web3 – Protecting Emerging Phygital Fashion Innovations

    These emerging phygital fashion innovations were on full display during the 2022 New York and Paris Fashion Weeks.
    United StatesIntellectual Property
    Rothwell, Figg, Ernst & Manbeck, P.C.
    Rothwell, Figg, Ernst & Manbeck, P.C.
  • Article

    The Current MRNA/LNP Patent Litigation Landscape

    Several patent litigations have been filed involving mRNA pioneers such as Moderna, Inc. and BioNTech, Inc. (with Pfizer) over the past year relating to sales of the Moderna and BioNTech/Pfizer COVID-19...
    United StatesIntellectual Property
    Rothwell, Figg, Ernst & Manbeck, P.C.
    Rothwell, Figg, Ernst & Manbeck, P.C.
  • Article

    Learning From Data Breach Cases To Reduce Legal Risk

    The average cost of a data breach is on the rise. According to the 2022 ForgeRock Consumer Identity Breach Report, the average cost in 2021 of recovering from a data breach in the U.S. is $9.5 million...
    United StatesPrivacy
    Rothwell, Figg, Ernst & Manbeck, P.C.
    Rothwell, Figg, Ernst & Manbeck, P.C.
  • Article

    The Proper Role For The Presumption Of Validity

    In 2011, the Supreme Court addressed the presumption of validity in Microsoft Corp. v. i4i Limited Partnership.
    United StatesIntellectual Property
    Rothwell, Figg, Ernst & Manbeck, P.C.
    Rothwell, Figg, Ernst & Manbeck, P.C.
  • Article

    Foodtech Pioneer Impossible Foods Sues Competitor Motif For Patent Infringement

    Investment in pioneer food tech companies has been on the rise.
    United StatesIntellectual Property
    Rothwell, Figg, Ernst & Manbeck, P.C.
    Rothwell, Figg, Ernst & Manbeck, P.C.
  • Article

    FTC Actions Hold Data Privacy Lessons For 2023

    The Federal Trade Commission will have its eye on privacy and data security enforcement in 2023.
    United StatesPrivacy
    Rothwell, Figg, Ernst & Manbeck, P.C.
    Rothwell, Figg, Ernst & Manbeck, P.C.
  • Article

    How To Deal With 'Patent Trolls' In The Digital Age

    Nonpracticing entities have targeted virtually every media organization in the United States with a significant digital presence for patent infringement lawsuits.
    United StatesIntellectual Property
    Rothwell, Figg, Ernst & Manbeck, P.C.
    Rothwell, Figg, Ernst & Manbeck, P.C.
  • Article

    How The U.S. Compares To Europe On Biosimilar Approvals And Products In The Pipeline Updated March 14, 2022

    As pharmaceutical drug costs attract increasing media attention and political scrutiny, a growing number of biosimilar drugs are set to enter the U.S. and European markets in the coming years.
    GlobalFood, Drugs, Healthcare, Life Sciences
    Rothwell, Figg, Ernst & Manbeck, P.C.
    Rothwell, Figg, Ernst & Manbeck, P.C.
  • Showing 41–53 of 53 results

    Previous
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics